Nano-X Imaging - NNOX Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $21.00
  • Forecasted Upside: 127.27%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$9.24
▲ +0.27 (3.01%)

This chart shows the closing price for NNOX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Nano-X Imaging Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NNOX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NNOX

Analyst Price Target is $21.00
▲ +127.27% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Nano-X Imaging in the last 3 months. The average price target is $21.00, with a high forecast of $21.00 and a low forecast of $21.00. The average price target represents a 127.27% upside from the last price of $9.24.

This chart shows the closing price for NNOX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in Nano-X Imaging. This rating has held steady since October 2022, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
8/7/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/5/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/3/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/4/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/2/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/31/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/30/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/29/2023

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/5/2023Cantor FitzgeraldInitiated CoverageOverweight$21.00Low
11/17/2021Lifesci CapitalDowngradeOutperform ➝ Market PerformLow
6/3/2021Lifesci CapitalReiterated RatingOutperformHigh
4/26/2021LADENBURG THALM/SH SHInitiated CoverageBuy$52.00Low
4/19/2021LADENBURG THALM/SH SHInitiated CoverageBuyHigh
2/1/2021Cantor FitzgeraldLower TargetOverweight$70.00 ➝ $67.00Low
10/1/2020OppenheimerReiterated RatingHoldHigh
9/22/2020OppenheimerReiterated RatingHoldLow
9/15/2020Berenberg BankInitiated CoverageBuy$65.00High
9/15/2020OppenheimerInitiated CoverageMarket PerformHigh
9/15/2020Cantor FitzgeraldInitiated CoverageOverweight$70.00High
(Data available from 1/29/2018 forward)

News Sentiment Rating

0.63 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/3/2022
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/2/2022
  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/1/2022
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
10/1/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
10/31/2022
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/30/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/30/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/29/2023

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Nano-X Imaging logo
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company develops a prototype of the Nanox.ARC, a medical imaging system incorporating its digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that would allow for the delivery of medical screening as a service. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was founded in 2011 and is headquartered in Neve Ilan, Israel.
Read More

Today's Range

Now: $9.24
Low: $8.91
High: $9.44

50 Day Range

MA: $8.98
Low: $6.57
High: $10.94

52 Week Range

Now: $9.24
Low: $6.41
High: $16.44

Volume

320,279 shs

Average Volume

438,523 shs

Market Capitalization

$481.22 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.74

Frequently Asked Questions

What sell-side analysts currently cover shares of Nano-X Imaging?

The following sell-side analysts have issued stock ratings on Nano-X Imaging in the last year: Cantor Fitzgerald.
View the latest analyst ratings for NNOX.

What is the current price target for Nano-X Imaging?

1 Wall Street analysts have set twelve-month price targets for Nano-X Imaging in the last year. Their average twelve-month price target is $21.00, suggesting a possible upside of 127.3%. Cantor Fitzgerald has the highest price target set, predicting NNOX will reach $21.00 in the next twelve months. Cantor Fitzgerald has the lowest price target set, forecasting a price of $21.00 for Nano-X Imaging in the next year.
View the latest price targets for NNOX.

What is the current consensus analyst rating for Nano-X Imaging?

Nano-X Imaging currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe NNOX will outperform the market and that investors should add to their positions of Nano-X Imaging.
View the latest ratings for NNOX.

What other companies compete with Nano-X Imaging?

How do I contact Nano-X Imaging's investor relations team?

Nano-X Imaging's physical mailing address is COMMUNICATIONS CENTER, NEVE ILAN L3, 9085000. The company's listed phone number is 972-02-995-0506 and its investor relations email address is [email protected] The official website for Nano-X Imaging is www.nanox.vision. Learn More about contacing Nano-X Imaging investor relations.